Rewind Therapeutics
Cheryl Zimberlin, PhD, joined M Ventures in May 2016 and is an Investment Director in the biotechnology team. Cheryl received her BSc. Hons. in Biology from the University of Utrecht, an MSc in Biotechnology from the University of Wageningen and a PhD in Oncology from the University of Amsterdam. Before joining M Ventures, she had a successful academic career publishing in top-tier academic journals, including Nature. Cheryl is based in Amsterdam and has board presence on several healthcare portfolio companies.
This person is not in the org chart
This person is not in any teams
This person is not in any offices
Rewind Therapeutics
Rewind Therapeutics is a developer of novel therapeutics intended to facilitate the treatment for neurological diseases.